Clinical trials
Breast - Female clinical trials
Below are recruiting breast - female clinical trials, each written for real people, not researchers. We’re tracking 3,615 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07816263Recruiting
Guaraná supplement for cancer-related fatigue
This trial tests whether a natural supplement called guaraná can help reduce fatigue in people undergoing cancer treatment. Guaraná contains caffeine and other compounds that may boost energy and improve well-being.
Bogotá, Bogota D.C.Ages 18 years+ - NCT07816601Recruiting
Donor breast milk for premature babies in the NICU
This study looks at whether giving donor breast milk to premature babies born between 29 and 32 weeks helps them feed better and grow. If your baby is in the NICU and eligible, they may receive donor breast milk for most of their feedings.
Orlando, FloridaAges 7 months–8 months - NCT07817056Recruiting
Managing blood sugar side effects from inavolisib
This study looks at how to best manage high blood sugar, a common side effect of the drug inavolisib, in people with a certain type of breast cancer. It aims to help patients stay on their treatment and improve their quality of life.
Tianjin, Tianjin MunicipalityAges 18 years+ - NCT06492187Recruiting
Survey to see if you qualify for infectious disease studies
This trial is a quick survey to see if you might be eligible for future infectious disease studies. It helps researchers understand your health background and find the right study for you.
Brooklyn, New YorkAges 18 years+ - NCT06466811Recruiting
Predicting blockages in external ventricular drains
This study looks at whether brain scans can help predict when a ventricular drain (a small tube placed in the brain to drain fluid) might get blocked. If researchers can predict blockages, they might be able to prevent complications.
Nantes, Loire-AtlantiqueAges 18 years+ - NCT05979155RecruitingPhase 1
Study of NWY001 for advanced solid tumors
This study tests a new experimental drug (NWY001) for people with advanced solid tumors that have stopped responding to standard treatments. It is a phase 1 trial, meaning it is early research to find the right dose and check for side effects.
Guangzhou, GuangdongAges 18–75 - NCT07807163RecruitingPhase 2
Study of ficerafusp alfa with pembrolizumab for head and neck cancer
This study tests a new drug called ficerafusp alfa combined with pembrolizumab (an immunotherapy) in people with head and neck cancer that has returned or spread. The drug targets a protein that may help the immune system fight the cancer. The study is comparing two different schedules of giving the drug to see which is better.
Fort Myers, FloridaAges 18 years+ - NCT07801508RecruitingPhase 1
Trial of a new imaging agent for people with advanced solid tumors
This trial tests a radioactive imaging agent that may help doctors see tumors more clearly using a special scan. It is designed for adults with certain breast, lung, or stomach cancers that have spread.
Darlinghurst, New South WalesAges 18 years+ - NCT07802704RecruitingPhase 3
Study of risvutatug rezetecan for advanced prostate cancer
This trial tests an experimental drug called Risvutatug Rezetecan for men with advanced prostate cancer that has stopped responding to standard hormone therapy. The drug works by targeting cancer cells and delivering a toxic agent directly to them, potentially slowing the cancer's growth.
Auchenflower, QueenslandAges 18 years+ - NCT05688176Recruiting
Testing blood RNA markers for esophagus cancer and Barrett’s
This study looks for helpful “RNA markers” found in blood to improve diagnosis in people with Barrett’s esophagus or esophageal cancer. It may help doctors spot disease more reliably, but it requires specific health and treatment conditions and a planned biopsy blood sample process.
Ghent, Oost-VlaanderenAges 18 years+ - NCT07802678RecruitingPhase 4
Stopping RA medicines in combination therapy
This study looks at whether people with rheumatoid arthritis who are stable on a TNF inhibitor plus another drug can safely stop the second drug. It aims to see if stopping the extra medicine keeps the disease under control and reduces side effects.
Nijmegen, GelderlandAges 18 years+ - NCT07806942Recruiting
Health mediation support for new mothers
This study tests a program that provides extra support to new mothers during their stay in the maternity ward. The goal is to help mothers and their babies have a better start, especially with breastfeeding and overall care.
Cayenne, GuyaneAges Any age - NCT07802353Recruiting
Focused radiation after brain tumor surgery
This study tests a type of radiation called stereotactic radiosurgery (SRS) given right after surgery to remove a brain tumor. The goal is to see if it helps control the tumor with fewer side effects.
Basking Ridge, New JerseyAges 18 years+ - NCT07808164Recruiting
Protein markers in solid tumors: a Vietnamese tissue study
This study looks at tissue samples from Vietnamese patients with solid tumors to understand the presence of certain proteins (ENPP1, cGAS, and FAP). The goal is to learn more about these tumors, which might help develop better treatments in the future.
Hanoi, HanoiAges 18 years+ - NCT04353557Recruiting
Blood test monitoring in early-stage breast cancer
This trial uses a special blood test to track cancer signals (called ctDNA) during and after treatment for early breast cancer. It aims to see whether monitoring these signals can help guide follow-up and treatment decisions.
Chongqing, Chongqing MunicipalityAges 18–80 - NCT03577197Recruiting
Breast cancer registry for advanced disease in southeast Netherlands
This trial is a cancer registry, meaning your medical information is collected and stored for people with advanced breast cancer. It can help researchers learn from real-world care patterns and outcomes across multiple hospitals in southeast Netherlands.
MaastrichtAges 18 years+ - NCT03676504RecruitingPhase 1/Phase 2
CAR T cell therapy for relapsed CD19 blood cancers
This trial tests a type of personalized immune treatment (CD19 CAR T cells made from your T cells) for adults (and children with ALL) whose CD19-positive blood cancer has come back or didn’t respond. It may help your immune system recognize and attack cancer cells that still have CD19.
HeidelbergAges 3 years+ - NCT07796178RecruitingPhase 4
Dry eye relief and comfort after cataract surgery
This study tests a treatment called Lacrifill to see if it helps reduce dry eye symptoms after cataract surgery. You would receive the treatment after your surgery to see if it improves comfort and eye health.
Pittsburg, KansasAges 18–80 - NCT06503380Recruiting
Managing blood side effects from breast cancer targeted drugs
This study looks at how well current methods manage low blood cell counts (low platelets, low white blood cells, and low red blood cells) that can happen from targeted therapies for breast cancer. If you have breast cancer and are getting or have gotten a targeted therapy, this trial could help improve care for side effects like these.
Shanghai, Not US/CanadaAges Any age - NCT06009315Recruiting
Stroke treatment outcome prediction study
This study looks at patients having a stroke procedure to remove a clot. It aims to predict how well people recover. If you are having this treatment, the study might help doctors understand your likely outcome.
Beijing, Beijing MunicipalityAges 18–100 - NCT05913427RecruitingPhase 2
Progesterone added to chemo for adrenal cancer that spread
This Phase 2 trial tests whether adding progesterone to standard chemotherapy improves outcomes for people with adrenal cortical carcinoma (ACC) that is locally advanced or has spread and cannot be removed with surgery. It also checks whether the treatment is safe and tolerable.
BresciaAges 18 years+ - NCT06485895Recruiting
Testing a new TB blood test for diagnosis
This study is testing a new blood test (IGRA) to see if it can help doctors diagnose active and latent (hidden) tuberculosis. If you are already being treated for TB and have had an IGRA blood test, you may be able to join.
MarseilleAges 18 years+ - NCT06534762RecruitingPhase 2
Miraberon for advanced solid tumors (first treatment)
This study tests a drug called Miraberon for people with advanced solid tumors that have not yet been treated with chemotherapy or other cancer drugs. The goal is to see if Miraberon can help shrink or control the cancer.
Hangzhou, ZhejiangAges 18–65 - NCT04679454Recruiting
One-dose pre-surgery radiation for early breast cancer
This study tests whether giving a single dose of radiation before breast surgery can be safe and effective for early-stage breast cancer. It may help by shrinking or treating the tumor right before the operation, depending on your case.
MilanAges 18 years+
Hear when a new Breast - Female trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for breast - female?
- Yes. Clin2 currently lists 3,615 recruiting breast - female studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a breast - female trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a breast - female trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.